TNF and tuberculosis: TB developed a median of 422 days [IQR 174–816] after first administration of anti-TNF agents (307 days [IQR 96–576] for infliximab, 312 days [IQR 167–572] for adalimumab, and 812 days [IQR 437–1,247] for etanercept).